+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hormone Replacement Therapy Market Size, Share & Trend Analysis By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 123 Pages
  • May 2023
  • Region: Global
  • Grand View Research
  • ID: 5010932
Description Jump to:
The global hormone replacement therapy market size is expected to reach USD 35.79 billion by 2030. The market is expected to expand at a CAGR of 6.6% from 2023 to 2030. The growth in the hormone replacement therapy market is largely attributable to the rising prevalence of hormonal disorders coupled with technological advancements in drug delivery systems. According to the National Organization of Rare Diseases, there are around 70,000 people with hypoparathyroidism in the U. S.

Technological advancements to minimize the side effects and enhance drug bioavailability are expected to boost the market growth. Due to better bioavailability, the treatment frequency increases. Products such as NGENLA, which is used to treat growth hormone deficiency, require a once-a-week dosage, which ensures better patient compliance. Furthermore, improvement in the route of administration is expected to boost the adoption of products. For instance, intranasal estrogen medication such as Nafarelin is comparatively more compliant in women than the conventional method.

Companies are taking initiatives such as collaboration, partnership, and agreement to expand their business footprint and generate revenue. For instance, in September 2021, Merck & Co., Inc. entered into an agreement with BIOCORP, a French company, for the development and distribution of the HGH monitoring device, Mallya. It is used to monitor and track daily HCG treatment. Such strategies are anticipated to propel the market growth during the forecast period.

Moreover, the launch of new hormone replacement therapy medicines in the market is anticipated to drive market growth. For instance, in November 2021, Fuji Pharma Co, Ltd. announced the launch of F-meno (100 mg capsule) for the prevention of endometrial hyperplasia on the administration of estrogen drugs for menopausal disorders. F-memo is an orally administered drug and is included in Japan’s National Health Insurance Drug Price list. This initiative may boost the prescription rate for hormone replacement therapy drugs, thereby driving the market growth.

However, severe adverse effects act as key restraints for market growth. The FDA has identified certain drugs in estrogen therapy that can cause adverse reactions and increase the risk of cancer in women. Premarin and Prempro, manufactured by Pfizer, are found to be associated with inducing cancer.

Hormone Replacement Therapy Market Highlights
- Based on the product, the estrogen & progesterone replacement therapy segment held the highest market share of 54.34% in 2022 and is estimated to maintain its dominance during the forecast period due to high demand due to the increasing number of women reaching menopause
- Parathyroid hormone replacement therapy is anticipated to witness the fastest growth during the forecast period due to the rising adoption of hormone replacement for the treatment of hypoparathyroidism
- Based on the route of administration, the oral segment dominated the market with a share of 42.48% in 2022 owing to the high prescription rate. Around 120 million prescriptions of Levothyroxine sodium tablets are being dispensed annually in the U. S
- Parenteral is expected to witness the fastest growth. The development and approval of long-acting products are expected to boost segment growth. For instance, in October 2021, Pfizer, Inc. received approval for its NGENLA (somatrogon), a once-a-week long-acting recombinant human growth hormone, from Health Canada for the treatment of a patient with growth hormone deficiency
- Menopause disease type segment dominated the market in 2022 with a share of 44.44% due to the rising number of women in the age group of 45 to 60 years and increasing incidence of vasomotor symptoms that may lead to severe conditions, such as osteoporosis, which are projected to fuel market growth

Table of Contents

Chapter 1 Methodology & Scope
1.1 Market Segmentation
1.1.1 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach 1: Commodity Flow Approach
1.6.1.2 Approach 2: Country-wise market estimation using bottom-up approach
1.7 Global Market: CAGR Calculation
1.8 Research Assumptions
1.9 List of Secondary Sources
1.10 List of Primary Sources
1.11 List of Abbreviations
1.12 Objectives
1.12.1 Objective 1
1.12.2 Objective 2
1.12.3 Objective 3
1.12.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Regulatory and Reimbursement Framework
3.4 Market Variable Analysis
3.4.1 Market driver analysis
3.4.1.1 Rising prevalence of hormonal disorders and increasing number of patients undergoing hormone replacement therapy
3.4.1.2 Technological developments in drug delivery systems
3.4.1.3 Increasing R&D investments and rising awareness about hormone deficiency
3.4.2 Market restraint analysis
3.4.2.1 High cost of treatment
3.4.2.2 Risk of side effects
3.5 Industry Analysis Tools
3.5.1 Porter's five forces analysis
3.6 Industry Analysis Tools
3.6.1 PESTEL Analysis
3.7 Pipeline Analysis
Chapter 4 Hormone Replacement Therapy Market - Segment Analysis, by Product Type, 2018 - 2030 (USD Billion)
4.1 HRT Market: Product Movement Analysis
4.2 Estrogen & Progesterone Replacement Therapy
4.2.1 Estrogen & Progesterone replacement therapy market, 2018 - 2030 (USD Billion)
4.3 Human Growth Hormone (HGH) Replacement Therapy
4.3.1 HGH replacement therapy market, 2018 - 2030 (USD Billion)
4.4 Thyroid Hormone Replacement Therapy
4.4.1 Thyroid hormone replacement therapy market, 2018 - 2030 (USD Billion)
4.5 Testosterone Replacement Therapy
4.5.1 Testosterone replacement therapy market, 2018 - 2030 (USD Billion)
4.6 Parathyroid Hormone Replacement
4.6.1 Parathyroid Hormone Replacement market, 2018 - 2030 (USD Billion)
Chapter 5 Hormone Replacement Therapy Market - Segment Analysis, by Route of Administration, 2018 - 2030 (USD Billion)
5.1 HRT Market: Route of Administration Movement Analysis
5.2 Oral
5.2.1 Oral market, 2018 - 2030 (USD Billion)
5.3 Parenteral
5.3.1 Parenteral market, 2018 - 2030 (USD Billion)
5.4 Transdermal
5.4.1 Transdermal market, 2018 - 2030 (USD Billion)
5.5 Others
5.5.1 Others market, 2018 - 2030 (USD Billion)
Chapter 6 Hormone Replacement Therapy Market - Segment Analysis, by Disease Type, 2018 - 2030 (USD Billion)
6.1 Hormone Replacement Therapy Market: Regional Outlook
6.2 North America
6.2.1 North America Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.2.2 U.S.
6.2.2.1 Key Country Dynamics
6.2.2.2 U.S. Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.2.2.3 Target Disease Prevalence
6.2.2.5 Competitive Scenario
6.2.2.6 Regulatory Framework
6.2.2.7 Reimbursement Scenario
6.2.3 Canada
6.2.3.1 Key Country Dynamics
6.2.3.2 Canada Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.2.3.3 Target Disease Prevalence
6.2.3.4 Competitive Scenario
6.2.3.5 Regulatory Framework
6.2.3.6 Reimbursement Scenario
6.3 Europe
6.3.1 Europe Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.3.2 U.K.
6.3.2.1 Key Country Dynamics
6.3.2.2 U.K. Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.3.2.3 Target Disease Prevalence
6.3.2.4 Competitive Scenario
6.3.2.5 Regulatory Framework
6.3.2.6 Reimbursement Scenario
6.3.3 Germany
6.3.3.1 Key Country Dynamics
6.3.3.2 Germany Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.3.3.3 Target Disease Prevalence
6.3.3.4 Competitive Scenario
6.3.3.5 Regulatory Framework
6.3.3.6 Reimbursement Scenario
6.3.4 France
6.3.4.1 Key Country Dynamics
6.3.4.2 France Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.3.4.3 Target Disease Prevalence
6.3.4.4 Competitive Scenario
6.3.4.5 Regulatory Framework
6.3.4.6 Reimbursement Scenario
6.3.5 Italy
6.3.5.1 Key Country Dynamics
6.3.5.2 Italy Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.3.5.3 Target Disease Prevalence
6.3.5.4 Competitive Scenario
6.3.5.5 Regulatory Framework
6.3.5.6 Reimbursement Scenario
6.3.6 Spain
6.3.6.1 Key Country Dynamics
6.3.6.2 Spain Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.3.6.3 Target Disease Prevalence
6.3.6.4 Competitive Scenario
6.3.6.5 Regulatory Framework
6.3.6.6 Reimbursement Scenario
6.3.7 Denmark
6.3.6.1 Key Country Dynamics
6.3.6.2 Denmark Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.3.6.3 Target Disease Prevalence
6.3.6.4 Competitive Scenario
6.3.6.5 Regulatory Framework
6.3.6.6 Reimbursement Scenario
6.3.8 Sweden
6.3.8.1 Key Country Dynamics
6.3.8.2 Sweden Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.3.8.3 Target Disease Prevalence
6.3.8.4 Competitive Scenario
6.3.8.5 Regulatory Framework
6.3.8.6 Reimbursement Scenario
6.3.9 Norway
6.3.9.1 Key Country Dynamics
6.3.9.2 Norway Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.3.9.3 Target Disease Prevalence
6.3.9.4 Competitive Scenario
6.3.9.5 Regulatory Framework
6.3.9.6 Reimbursement Scenario
6.4 Asia Pacific
6.4.1 Asia Pacific Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.4.2 Japan
6.4.2.1 Key Country Dynamics
6.4.2.2 Japan Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.4.2.3 Target Disease Prevalence
6.4.2.4 Competitive Scenario
6.4.2.5 Regulatory Framework
6.4.2.6 Reimbursement Scenario
6.4.3 China
6.4.3.1 Key Country Dynamics
6.4.3.2 China Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.4.3.3 Target Disease Prevalence
6.4.3.4 Competitive Scenario
6.4.3.5 Regulatory Framework
6.4.3.6 Reimbursement Scenario
6.4.4 India
6.4.4.1 Key Country Dynamics
6.4.4.2 India Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.4.4.3 Target Disease Prevalence
6.4.4.4 Competitive Scenario
6.4.4.5 Regulatory Framework
6.4.4.6 Reimbursement Scenario
6.4.5 Australia
6.4.5.1 Key Country Dynamics
6.4.5.2 Australia Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.4.5.3 Target Disease Prevalence
6.4.5.4 Competitive Scenario
6.4.5.5 Regulatory Framework
6.4.5.6 Reimbursement Scenario
6.4.6 South Korea
6.4.6.1 Key Country Dynamics
6.4.6.2 South Korea Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.4.6.3 Target Disease Prevalence
6.4.6.4 Competitive Scenario
6.4.6.5 Regulatory Framework
6.4.6.6 Reimbursement Scenario
6.4.7 Thailand
6.4.7.1 Key Country Dynamics
6.4.7.2 Thailand Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.4.7.3 Target Disease Prevalence
6.4.7.4 Competitive Scenario
6.4.7.5 Regulatory Framework
6.4.7.6 Reimbursement Scenario
6.5 Latin America
6.5.1 Latin America Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.5.2 Brazil
6.5.2.1 Key Country Dynamics
6.5.2.2 Brazil Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.5.2.3 Target Disease Prevalence
6.5.2.4 Competitive Scenario
6.5.2.5 Regulatory Framework
6.5.2.6 Reimbursement Scenario
6.5.3 Mexico
6.5.3.1 Key Country Dynamics
6.5.3.2 Mexico Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.5.3.3 Target Disease Prevalence
6.5.3.4 Competitive Scenario
6.5.3.5 Regulatory Framework
6.5.3.6 Reimbursement Scenario
6.5.4 Argentina
6.5.4.1 Key Country Dynamics
6.5.4.2 Argentina Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.5.4.3 Target Disease Prevalence
6.5.4.4 Competitive Scenario
6.5.4.5 Regulatory Framework
6.5.4.6 Reimbursement Scenario
6.6 Middle East and Africa
6.6.1 Middle East and Africa Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.6.1.1 Target Disease Prevalence
6.6.1.2 Competitive Scenario
6.6.1.3 Regulatory Framework
6.6.1.4 Reimbursement Scenario
6.6.2 South Africa
6.6.2.1 Key Country Dynamics
6.6.2.2 South Africa Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.6.2.3 Target Disease Prevalence
6.6.2.4 Competitive Scenario
6.6.2.5 Regulatory Framework
6.6.2.6 Reimbursement Scenario
6.6.3 Saudi Arabia
6.6.3.1 Key Country Dynamics
6.6.3.2 Saudi Arabia Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.6.3.3 Target Disease Prevalence
6.6.3.4 Competitive Scenario
6.6.3.5 Regulatory Framework
6.6.3.6 Reimbursement Scenario
6.6.4 UAE
6.6.4.1 Key Country Dynamics
6.6.4.2 UAE Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.6.4.3 Target Disease Prevalence
6.6.4.4 Competitive Scenario
6.6.4.5 Regulatory Framework
6.6.4.6 Reimbursement Scenario
6.6.5 Kuwait
6.6.5.1 Key Country Dynamics
6.6.5.2 Kuwait Hormone Replacement Therapy Market Estimates & Forecasts, 2018 - 2030 (USD Billion)
6.6.5.3 Target Disease Prevalence
6.6.5.4 Competitive Scenario
6.6.5.5 Regulatory Framework
6.6.5.6 Reimbursement Scenario
Chapter 7 Hormone Replacement Therapy Market - Competitive Analysis
7.1 Company Categorization
7.2 Participant’s Overview
7.3 Financial Performance
7.4 Product Benchmarking
7.5 Company Market Positioning
7.6 Company Market Share Analysis, 2022
7.7 Company Heat Map Analysis
7.8 Strategic Initiatives
7.9 Company Profiles
7.9.1 Bayer AG
7.9.2 Pfizer, Inc.
7.9.3 Merck & Co., Inc.
7.9.4 Viatris Inc.
7.9.5 Novo Nordisk A/S
7.9.6 Eli Lilly and Company
7.9.7 F. Hoffmann-La Roche Ltd. (Genentech)
7.9.8 Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
7.9.9 ASCEND Therapeutics US, LLC. (Besins Healthcare)
7.9.10 AbbVie Inc.
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 Regulatory Framework
Table 4 Leading Market Players Anticipated to Witness Highest Growth.
Table 5 List of Key Distributors and Compounding Pharmacies
Table 6 North America Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 7 North America Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 8 North America Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 9 U.S. Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 10 U.S. Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 11 U.S. Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 12 Canada Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 13 Canada Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 14 Canada Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 15 Europe Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 16 Europe Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 17 Europe Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 18 UK Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 19 UK Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 20 UK Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 21 Germany Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 22 Germany Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 23 Germany Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 24 France Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 25 France Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 26 France Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 27 Italy Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 28 Italy Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 29 Italy Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 30 Spain Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 31 Spain Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 32 Spain Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 33 Denmark Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 34 Denmark Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 35 Denmark Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 36 Sweden Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 37 Sweden Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 38 Sweden Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 39 Norway Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 40 Norway Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 41 Norway Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 42 Asia Pacific Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 43 Asia Pacific Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 44 Asia Pacific Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 45 Japan Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 46 Japan Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 47 Japan Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 48 China Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 49 China Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 50 China Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 51 India Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 52 India Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 53 India Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 54 Australia Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 55 Australia Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 56 Australia Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 57 South Korea Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 58 South Korea Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 59 South Korea Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 60 Thailand Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 61 Thailand Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 62 Thailand Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 63 Latin America Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 64 Latin America Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 65 Latin America Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 66 Brazil Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 67 Brazil Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 68 Brazil Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 69 Mexico Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 70 Mexico Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 71 Mexico Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 72 Argentina Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 73 Argentina Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 74 Argentina Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 75 Middle East & Africa Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 76 Middle East & Africa Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 77 Middle East & Africa Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 78 South Africa Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 79 South Africa Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 80 South Africa Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 81 Saudi Arabia Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 82 Saudi Arabia Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 83 Saudi Arabia Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 84 UAE Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 85 UAE Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 86 UAE Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
Table 87 Kuwait Hormone Replacement Therapy Market, By Product, 2018 - 2030 (USD Billion)
Table 88 Kuwait Hormone Replacement Therapy Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 89 Kuwait Hormone Replacement Therapy Market, By Disease Type, 2018 - 2030 (USD Billion)
List of Figures
Fig. 1 Hormone Replacement Therapy Market Segmentation
Fig. 2 Market Research Process
Fig. 3 Information Procurement
Fig. 4 Primary Research Pattern
Fig. 5 Market Research Approaches
Fig. 6 Value-chain-Based Sizing & Forecasting
Fig. 7 QFD Modelling for Market Share Assessment
Fig. 8 Market Formulation & Validation
Fig. 9 Market Summary
Fig. 10 Penetration & Growth Prospect Mapping
Fig. 11 Market Driver Impact Analysis (Current & future impact)
Fig. 12 Market restraint impact analysis (Current & future impact)
Fig. 13 Porter's Five Forces Analysis
Fig. 14 HRT market product outlook: Key takeaways
Fig. 16 Estrogen & progesterone replacement therapy market, 2018 - 2030 (USD Billion)
Fig. 17 HGH replacement therapy market, 2018 - 2030 (USD Billion)
Fig. 18 Thyroid hormone replacement therapy market, 2018 - 2030 (USD Billion)
Fig. 19 Testosterone replacement therapy market, 2018 - 2030 (USD Billion)
Fig. 20 Parathyroid hormone market, 2018 - 2030 (USD Billion)
Fig. 21 HRT market route of administration outlook: Key takeaways
Fig. 22 HRT market: Route of administration movement analysis
Fig. 23 Oral market, 2018 - 2030 (USD Billion)
Fig. 24 Parenteral market, 2018 - 2030 (USD Billion)
Fig. 25 Transdermal market, 2018 - 2030 (USD Billion)
Fig. 26 Others market, 2018 - 2030 (USD Billion)
Fig. 27 HRT market disease type outlook: Key takeaways
Fig. 28 HRT market: Disease type movement analysis
Fig. 29 Menopause market, 2018 - 2030 (USD Billion)
Fig. 30 Hypothyroidism market, 2018 - 2030 (USD Billion)
Fig. 31 Male hypogonadism market, 2018 - 2030 (USD Billion)
Fig. 32 Growth hormone deficiency market, 2018 - 2030 (USD Billion)
Fig. 33 Hypoparathyroidism, 2018 - 2030 (USD Billion)
Fig. 34 HRT regional outlook
Fig. 35 Regional outlook, 2021 & 2030
Fig. 36 North America SWOT analysis
Fig. 37 North America. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 U.S. key country dynamics
Fig. 39 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Canada key country dynamics
Fig. 41 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Europe SWOT analysis
Fig. 43 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 UK key country dynamics
Fig. 45 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Germany key country dynamics
Fig. 47 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 France key country dynamics
Fig. 49 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Spain key country dynamics
Fig. 51 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Italy key country dynamics
Fig. 53 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Denmark key country dynamics
Fig. 55 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 56 Sweden key country dynamics
Fig. 57 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 58 Norway key country dynamics
Fig. 59 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 60 Asia-Pacific SWOT analysis
Fig. 61 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 62 Japan key country dynamics
Fig. 63 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 64 China key country dynamics
Fig. 65 China. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 66 India key country dynamics
Fig. 67 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 68 Australia key country dynamics
Fig. 69 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 70 South Korea key country dynamics
Fig. 71 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 72 Thailand key country dynamics
Fig. 73 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 74 Latin America SWOT analysis
Fig. 75 Latin America. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 76 Brazil key country dynamics
Fig. 77 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 78 Mexico key country dynamics
Fig. 79 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 80 Argentina key country dynamics
Fig. 81 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 82 Middle East & Africa SWOT analysis
Fig. 83 MEA market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 84 South Africa key country dynamics
Fig. 85 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 86 Saudi Arabia key country dynamics
Fig. 87 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 88 UAE key country dynamics
Fig. 89 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 90 Kuwait key country dynamics
Fig. 91 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Companies Mentioned

  • Bayer AG
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Viatris Inc.
  • Novo Nordisk A/S
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd. (Genentech)
  • Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
  • ASCEND Therapeutics US, LLC. (Besins Healthcare)
  • AbbVie Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages123
PublishedMay 2023
Forecast Period2022 - 2030
Estimated Market Value ( USD ) in 2022 $ 21.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 35.79 Billion
Compound Annual Growth Rate6.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Hormone Replacement Therapy Market by Type, Route of Administration - Global Forecast 2025-2030 - Product Image

Hormone Replacement Therapy Market by Type, Route of Administration - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Hormone Replacement Therapy Market Overview, 2024-2029 - Product Image

Hormone Replacement Therapy Market Overview, 2024-2029

  • Report
  • 105 Pages
  • Global
From
Hormone Replacement Therapy Market Outlook, 2029 - Product Image

Hormone Replacement Therapy Market Outlook, 2029

  • Report
  • 192 Pages
  • Global
From
Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Hormone Replacement Therapy - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2024-2032 - Product Image

Hormone Replacement Therapy Market Report by Product, Route of Administration, Type of Disease, and Region 2024-2032

  • Report
  • 143 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.